These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 22513344

  • 21. [Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].
    Macín SM, Perna ER, Címbaro Canella JP, Alvarenga P, Pantich R, Ríos N, Farías EF, Badaracco JR.
    Rev Esp Cardiol; 2004 Jan; 57(1):45-52. PubMed ID: 14746717
    [Abstract] [Full Text] [Related]

  • 22. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA, Peñafiel P, Nicolas F, de la Morena G, Ansaldo P, Redondo B, Sánchez Mas J, Valdés M.
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [Abstract] [Full Text] [Related]

  • 23. QT interval dispersion in patients with chronic heart failure secondary to Chagas' cardiomyopathy: correlation with clinical variables of prognostic significance.
    Corbucci HA, Haber DM, Bestetti RB, Cordeiro JA, Fioroni ML.
    Cardiovasc Pathol; 2006 Mar; 15(1):18-23. PubMed ID: 16414452
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
    Kubota T, Takeshita A.
    Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
    [Abstract] [Full Text] [Related]

  • 25. Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation.
    Boldt LH, Rolf S, Huemer M, Parwani AS, Luft FC, Dietz R, Haverkamp W.
    Am Heart J; 2008 May; 155(5):890-5. PubMed ID: 18440338
    [Abstract] [Full Text] [Related]

  • 26. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME, Berliner JI, Shah SJ, Taegtmeyer H, Gheorghiade M.
    Am J Ther; 2008 May; 15(3):206-13. PubMed ID: 18496257
    [Abstract] [Full Text] [Related]

  • 27. From left ventricular dysfunction to heart failure.
    Cleland JG.
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398
    [Abstract] [Full Text] [Related]

  • 28. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, Sullivan T, Worthley SG, De Pasquale CG, Sanders P, Selvanayagam JB.
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [Abstract] [Full Text] [Related]

  • 29. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S, Dayi SU, Akbulut T, Dağ O, Köse H, Satiroğlu O, Sayar N, Bilsel T, Aksoy S, Yeşilçimen K.
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
    [Abstract] [Full Text] [Related]

  • 30. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
    Shen L, Ramires F, Martinez F, Bodanese LC, Echeverría LE, Gómez EA, Abraham WT, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV, PARADIGM-HF and ATMOSPHERE Investigators and Committees.
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
    [Abstract] [Full Text] [Related]

  • 31. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ, Vetrovec GW, Gorelik D, Froelicher VF.
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [Abstract] [Full Text] [Related]

  • 32. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E, Perez-Villa F, Morales M, Jiménez W, Orús J, Heras M, Sanz G.
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [Abstract] [Full Text] [Related]

  • 33. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
    Tsuyuki RT, Yusuf S, Rouleau JL, Maggioni AP, McKelvie RS, Wiecek EM, Wang Y, Pogue J, Teo KK, White M, Avezum A, Latini R, Held P, Lindgren E, Probstfield J.
    Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
    [Abstract] [Full Text] [Related]

  • 34. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M, Furumoto T, Kinugawa S, Hamaguchi S, Goto K, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H, JCARE-CARD Investigators.
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [Abstract] [Full Text] [Related]

  • 35. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R, Wang Y, Foody JM.
    Am J Cardiol; 2008 Jan 15; 101(2):217-22. PubMed ID: 18178410
    [Abstract] [Full Text] [Related]

  • 36. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M, French National College of Cardiologists.
    Arch Cardiovasc Dis; 2012 Jan 15; 105(6-7):355-65. PubMed ID: 22800720
    [Abstract] [Full Text] [Related]

  • 37. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.
    Rickenbacher PR, Trindade PT, Haywood GA, Vagelos RH, Schroeder JS, Willson K, Prikazsky L, Fowler MB.
    J Am Coll Cardiol; 1996 Apr 15; 27(5):1192-7. PubMed ID: 8609341
    [Abstract] [Full Text] [Related]

  • 38. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure.
    Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT, Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) Study Group.
    Circulation; 2010 Mar 09; 121(9):1086-95. PubMed ID: 20176990
    [Abstract] [Full Text] [Related]

  • 39. Treating patients with Chagas' cardiomyopathy with chronic heart failure in the contemporary era.
    Bestetti RB, Theodoropoulos TA, Cardinalli-Neto A.
    Am Heart J; 2007 Nov 09; 154(5):e35; author reply e33. PubMed ID: 17967576
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2009 Apr 09; 20(4):395-400. PubMed ID: 19017351
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.